Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 349
Titolo Data di pubblicazione Autore(i) File
Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma 1-gen-2003 Sanguineti, G.; Bossi, P.; Pou, A.; Licitra, L.
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 1-gen-2003 Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L.
Head and neck cancer 1-gen-2004 Licitra, L.; Locati, L. D.; Bossi, P.
Head and neck tumors other than squamous cell carcinoma 1-gen-2004 Licitra, L.; Locati, L. D.; Bossi, P.; Cantu, G.
Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy 1-gen-2004 Palazzi, M.; Guzzo, M.; Bossi, P.; Tomatis, S.; Cerrotta, A.; Cantu, G.; Locati, L. D.; Licitra, L.
Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma 1-gen-2004 Licitra, L.; Suardi, S.; Bossi, P.; Locati, L. D.; Mariani, L.; Quattrone, P.; Lo Vullo, S.; Oggionni, M.; Olmi, P.; Cantu, G.; Pierotti, M. A.; Pilotti, S.
Herceptin® plus chemotherapy in relapsed and/or metastatic salivary gland cancer [1] 1-gen-2005 Locati, L. D.; Rinaldi, G.; Bossi, P.; Dagrada, G. P.; Quattrone, P.; Cantu, G.; Licitra, L.
Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas? 1-gen-2005 Bergamini, C.; Barisella, M.; Locati, L. D.; Bossi, P.; Potepan, P.; Rinaldi, G.; Licitra, L.
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15] 1-gen-2005 Licitra, L.; Bossi, P.; Locati, L. D.; Bergamini, C.
Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland 1-gen-2005 Locati, L. D.; Guzzo, M.; Bossi, P.; Massone, P. P. B.; Conti, B.; Fumagalli, E.; Bareggi, C.; Cantu, G.; Licitra, L.
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma 1-gen-2006 Licitra, L; Perrone, F; Bossi, P; Suardi, S; Mariani, L; Artusi, R; Oggionni, M; Rossini, C; Cantu, G; Squadrelli, M; Quattrone, P; Locati, Ld; Bergamini, C; Olmi, P; Pierotti, Ma; Pilotti, S
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 1-gen-2006 Perrone, F.; Suardi, S.; Pastore, E.; Casieri, P.; Orsenigo, M.; Caramuta, S.; Dagrada, G.; Losa, M.; Licitra, L.; Bossi, P.; Staurengo, S.; Oggionni, M.; Locati, L.; Cantu, G.; Squadrelli, M.; Carbone, A.; Pierotti, M. A.; Pilotti, S.
Advances in the changing patterns of aetiology of head and neck cancers 1-gen-2006 Licitra, L.; Rossini, C.; Bossi, P.; Locati, L. D.
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new? 1-gen-2006 Licitra, L.; Bossi, P.; Locati, L. D.
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients 1-gen-2007 Bossi, P; Liberatoscioli, C; Bergamini, C; Locati, Ld; Fava, S; Rinaldi, G; Orlandi, E; Olmi, P; Tagliabue, E; Menard, S; Licitra, L
T-cell therapy for the control of EBV-related nasopharyngeal carcinoma 1-gen-2007 Secondino, S; Basso, S; Pedrazzoli, P; Bossi, P; Labirio, M; Basilico, V; Locati, L; Schiavetto, I; Maccario, R; Licitra, L; Locatelli, F; Siena, S; Comoli, P
Optimizing the treatment of nasopharyngeal cancer: Anupdate of the milan experience including imrt and chemotherapy intensification 1-gen-2007 Palazzi, M; Tomatis, S; Orlandi, E; Bossi, P; Guzzo, M; Potepan, P; Pignoli, E; Bergamini, C; Licitra, L; Scaramellini, G; Cantu, G; Olmi, P
New insights in chemotherapy 1-gen-2007 Licitra, L; Locati, Ld; Bossi, P
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC) 1-gen-2007 Bergamini, C; Bossi, P; Orlandi, E; Locati, L; Liberatoscioli, C; Fallai, C; Palazzi, M; Olmi, P; Licitra, L
Relationship between parotid glands dose and salivary toxicity in patients receiving intensity modulated radiation therapy (IMRT) and chemotherapy for nasopharyngeal carcinoma: Preliminary results 1-gen-2007 Orlandi, E; Pignoli, E; Palazzi, M; Zonca, G; Tomatis, S; Sangalli, C; Bossi, P; Bergamini, C; Locati, Ld; Licitra, L; Olmi, P
Mostrati risultati da 1 a 20 di 349
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile